1,315 research outputs found
Effective Evacuation Route Strategy during Natural Disaster
Nowadays, most of the countries around the world encounter affect of disasters. Disaster can occur anytime and anywhere, without giving any alarm or message. During the disaster, the rapid response and recovery activities are critical issues to save lives and properties. The effective response actions play vital role in the disaster situation because the large amount of properties and valuable lives are depending on it. But, the rescue teams and emergency organizations have many problems and delays to give the effective response to the victim areas. To reduce the risk and damage, identifying the best evacuation routes for the recuse teams is vital. The proposed system provides not only the recuse teams which locate near the victim area but also the best evacuation routes to move people from the hazard place to the safe places. This paper describes a web-based application for the best evacuation route assessment during natural disaster
The pale evidence for treatment of iron-deficiency anaemia in older people
Funding The authors have received funding to carry out a pilot RCT on management of IDA in older people from the Chief Scientist Office, Scotland.Peer reviewedPostprin
A Review of Frailty Syndrome and Its Physical, Cognitive and Emotional Domains in the Elderly
Peer reviewedPublisher PD
Association between osteoarthritis and cardiovascular disease: systematic review and meta-analysis
Background: To examine for a possible relationship between osteoarthritis and cardiovascular disease (CVD). Design: A systematic review and meta-analysis Methods: Published and unpublished literature from: MEDLINE, EMBASE, CINAHL, the Cochrane Library, OpenGrey and clinical trial registers. Search to 22nd November 2014. Cohort, case-control, randomised and non-randomised controlled trial papers reporting the prevalence of CVD in osteoarthritis were included. Results: Fifteen studies with 32,278,744 individuals were eligible. Pooled prevalence for overall CVD pathology in people with osteoarthritis was 38.4% (95% Confidence interval (CI): 37.2% to 39.6%). Individuals with osteoarthritis were almost three times as likely to have heart failure (Relative Risk (RR): 2.80; 95% CI: 2.25 to 3.49) or ischaemic heart disease (RR: 1.78; 95% CI: 1.18 to 2.69) compared to matched non-osteoarthritis cohorts. No significant difference was detected between the two groups for the risk of experiencing myocardial infarction or stroke. There was a three-fold decrease in the risk of experiencing a transient ischaemic attack in the osteoarthritis cohort compared to the non-osteoarthritis group. Conclusions: Prevalence of CVD in patients with OA is significant. There was an observed increased risk of incident heart failure and ischaemic heart disease in people with OA compared to matched controls. However the relationship between OA and CVD is not straight-forward and there is a need to better understand the potential common pathways linking pathophysiological mechanisms
Should bone mineral content be part of the equation for assessing fracture risk in patients with Cerebral Palsy
Peer reviewedPostprin
Stochastic Variational Search for H
A four-body calculation of the bound state, $^{\
4}_{\Lambda\Lambda}NN\Lambda N\Lambda\Lambda\Lambda\Lambda_\Lambda^3{H}+\Lambda\Lambda\LambdaB_{\Lambda\Lambda}(^{6}_{\Lambda\Lambda}{He})d\Lambda\Lambda$ model in the Letter.Comment: Corrected typos, added addtional calculations regarding a truncated
to l=0 interaction model, 4 pages, 3 figure
Prognostic value of troponins in acute coronary syndrome depends upon patient age
Peer reviewedPostprin
Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke:Pooled analysis of randomized trials
Background and Purpose: Lacunar stroke accounts for ≈25% of ischemic stroke, but optimal antiplatelet regimen to prevent stroke recurrence remains unclear. We aimed to evaluate the efficacy of antiplatelet agents in secondary stroke prevention after a lacunar stroke. Methods: We searched MEDLINE, Embase, and the Cochrane library for randomized controlled trials that reported risk of recurrent stroke or death with antiplatelet therapy in patients with lacunar stroke. We used random effects meta-analysis and evaluated heterogeneity with I2. Results: We included 17 trials with 42 234 participants (mean age 64.4 years, 65% male) and follow up ranging from 4 weeks to 3.5 years. Compared with placebo, any single antiplatelet agent was associated with a significant reduction in recurrence of any stroke (risk ratio [RR] 0.77, 0.62–0.97, 2 studies) and ischemic stroke (RR 0.48, 0.30–0.78, 2 studies), but not for the composite outcome of any stroke, myocardial infarction, or death (RR 0.89, 0.75–1.05, 2 studies). When other antiplatelet agents (ticlodipine, cilostazol, and dipyridamole) were compared with aspirin, there was no consistent reduction in stroke recurrence (RR 0.91, 0.75–1.10, 3 studies). Dual antiplatelet therapy did not confer clear benefit over monotherapy (any stroke RR 0.83, 0.68–1.00, 3 studies; ischemic stroke RR 0.80, 0.62–1.02, 3 studies; composite outcome RR 0.90, 0.80–1.02, 3 studies). Conclusions: Our results suggest that any of the single antiplatelet agents compared with placebo in the included trials is adequate for secondary stroke prevention after lacunar stroke. Dual antiplatelet therapy should not be used for long-term stroke prevention in this stroke subtype
A Framework for Elder-Friendly Public Open Spaces from the Iranian Older Adults' perspectives : A Mixed-Method Study
Authors' contributions All of the authors have made great contributions to the research design, field survey, data collection, data analysis, and drafting of the manuscript. Funding There are no funding resources for this research. Availability of data and materials The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.Peer reviewedPostprin
- …